SCHRODER INVESTMENT MANAGEMENT GROUP

Position in VERA — Vera Therapeutics, Inc.

CIK 1086619 London, X0

Position in VERA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$21,917,869

+$2,431,222 QoQ

Shares Held

510,787

+5.5% QoQ

Ownership

0.709%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#33

of 218 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. VERA ranks #7 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,410,943	$99,683,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	169,270	$84,081,485
3	EXEL	Exelixis, Inc.	669,005	$36,400,560
4	INSM	INSMED Inc	298,372	$31,812,422
5	ALNY	Alnylam Pharmaceuticals, Inc.	95,194	$28,656,248
6	MDGL	Madrigal Pharmaceuticals, Inc.	51,630	$27,722,728
7	VERA	Vera Therapeutics, Inc. This page	510,787	$21,917,869
8	TVTX	Travere Therapeutics, Inc.	379,611	$21,565,700

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,917,869	510,787	+5.5%	Shares	Sole	2026-08-13
2026-03-31	$19,486,647	484,381	+1424.2%	Shares	Sole	2026-05-14
2025-12-31	$1,609,288	31,779	-95.3%	Shares	Sole	2026-02-13
2025-09-30	$19,760,567	679,992	+82.4%	Shares	Sole	2025-11-13
2025-06-30	$8,781,966	372,749	-18.8%	Shares	Sole	2025-08-13
2025-03-31	$11,021,360	458,841	-5.4%	Shares	Sole	2025-05-13
2024-12-31	$20,516,782	485,145	+1.8%	Shares	Sole	2025-02-12
2024-09-30	$21,070,714	476,713	+10.1%	Shares	Sole	2024-11-13
2024-06-30	$15,672,162	433,172	+23.2%	Shares	Sole	2024-08-12
2024-03-31	$15,163,277	351,653	-68.3%	Shares	Sole	2024-05-14
2023-12-31	$17,086,564	1,110,960	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.